Top 100 Contractors in NAICS 325414: Biological Product (except Diagnostic) Manufacturing, FY2025

Parent companies by net contract obligations Oct 1, 2024 – Sep 30, 2025 Code page on GovTribe

The top 10 won 81% of FY2025 NAICS 325414 contract dollars

Ranking facts

Contract obligations
-$30,290,295 Net of deobligations, by contracts coded NAICS 325414
Contractors
112 Parent companies with an obligation
Largest contractor
Emergent Biosolutions Inc. $55.7 million, 28.0% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV · Free to reuse with credit to GovTribe (CC BY 4.0)

Full ranking

Rank Contractor Net obligations Share Trend
1 $55,745,371
Rank history: not on the FY2021–FY2023 lists and #3 in FY2024; up 2 since FY2024.
2 $41,987,919
Rank history: not on the FY2021–FY2023 lists and #14 in FY2024; up 12 since FY2024.
3 $19,484,878
Rank history: #21 in FY2021, #79 in FY2022, #13 in FY2023 and #4 in FY2024; up 1 since FY2024.
4 $8,054,662
Rank history: not on the FY2021–FY2023 lists and #11 in FY2024; up 7 since FY2024.
5 $7,638,116
Rank history: #7 in FY2021, not on the FY2022–FY2023 lists and #5 in FY2024; unchanged since FY2024.
6
Boehringer Ingelheim Animal Health USA Inc
$7,597,312
Rank history: #28 in FY2021, #23 in FY2022, #7 in FY2023 and #10 in FY2024; up 4 since FY2024.
7 $6,400,078
Rank history: #13 in FY2021, #8 in FY2022, #8 in FY2023 and #12 in FY2024; up 5 since FY2024.
8 $5,500,000
Rank history: not on the FY2021–FY2024 lists; new.
9 $5,480,000
Rank history: not on the FY2021–FY2023 lists and #9 in FY2024; unchanged since FY2024.
10 $4,459,878
Rank history: #26 in FY2021, #3 in FY2022, #3 in FY2023 and #6 in FY2024; down 4 since FY2024.
11 $3,112,500
Rank history: #14 in FY2021, #18 in FY2022, #9 in FY2023 and not on the FY2024 list; returned.
12 $2,468,906
Rank history: #18 in FY2021, #10 in FY2022, #11 in FY2023 and #13 in FY2024; up 1 since FY2024.
13 $2,069,424
Rank history: not on the FY2021–FY2024 lists; new.
14 $1,779,470
Rank history: not on the FY2021–FY2024 lists; new.
15 $1,530,320
Rank history: #54 in FY2021, not on the FY2022–FY2023 lists and #16 in FY2024; up 1 since FY2024.
16 $1,456,500
Rank history: not on the FY2021–FY2023 lists and #25 in FY2024; up 9 since FY2024.
17 $817,576
Rank history: #19 in FY2021, #13 in FY2022, #10 in FY2023 and #17 in FY2024; unchanged since FY2024.
18 $741,722
Rank history: not on the FY2021–FY2024 lists; new.
19 $617,837
Rank history: #25 in FY2021, #19 in FY2022, not on the FY2023 list and #27 in FY2024; up 8 since FY2024.
20 $567,767
Rank history: not on the FY2021 list, #17 in FY2022, #19 in FY2023 and not on the FY2024 list; returned.
21 $541,455
Rank history: not on the FY2021–FY2024 lists; new.
22 $536,223
Rank history: #12 in FY2021, #7 in FY2022, #12 in FY2023 and #52 in FY2024; up 30 since FY2024.
23 $517,235
Rank history: #53 in FY2021, not on the FY2022 list, #23 in FY2023 and #49 in FY2024; up 26 since FY2024.
24 $431,180
Rank history: not on the FY2021–FY2023 lists and #15 in FY2024; down 9 since FY2024.
25 $387,892
Rank history: not on the FY2021–FY2024 lists; new.
26 $376,365
Rank history: not on the FY2021–FY2023 lists and #73 in FY2024; up 47 since FY2024.
27 $375,761
Rank history: not on the FY2021–FY2024 lists; new.
28 $374,685
Rank history: #33 in FY2021, #27 in FY2022, #22 in FY2023 and not on the FY2024 list; returned.
29 $359,179
Rank history: not on the FY2021–FY2024 lists; new.
30 $352,364
Rank history: not on the FY2021–FY2024 lists; new.
31 $343,245
Rank history: #88 in FY2021, #32 in FY2022, #48 in FY2023 and #23 in FY2024; down 8 since FY2024.
32 $342,998
Rank history: not on the FY2021–FY2024 lists; new.
33
Fujifilm Holdings America Corporation Through Fujifilm Biosciences Inc.
$336,635
Rank history: not on the FY2021–FY2024 lists; new.
34 $321,535
Rank history: not on the FY2021–FY2023 lists and #39 in FY2024; up 5 since FY2024.
35 $314,545
Rank history: #56 in FY2021, #42 in FY2022, #34 in FY2023 and #35 in FY2024; unchanged since FY2024.
36 $273,720
Rank history: not on the FY2021–FY2024 lists; new.
37 $273,644
Rank history: not on the FY2021–FY2022 lists, #16 in FY2023 and #41 in FY2024; up 4 since FY2024.
38 $269,874
Rank history: not on the FY2021–FY2024 lists; new.
39 $264,917
Rank history: not on the FY2021 list, #37 in FY2022, #38 in FY2023 and #34 in FY2024; down 5 since FY2024.
40 $262,291
Rank history: #41 in FY2021, #39 in FY2022, #42 in FY2023 and #54 in FY2024; up 14 since FY2024.
41 $260,637
Rank history: #15 in FY2021, #30 in FY2022, #27 in FY2023 and #46 in FY2024; up 5 since FY2024.
42 $250,000
Rank history: #36 in FY2021, not on the FY2022 list, #29 in FY2023 and not on the FY2024 list; returned.
43 $248,878
Rank history: not on the FY2021–FY2023 lists and #70 in FY2024; up 27 since FY2024.
44 $223,149
Rank history: not on the FY2021 list, #68 in FY2022, #52 in FY2023 and not on the FY2024 list; up 59 since FY2024.
45 $204,272
Rank history: #52 in FY2021, #38 in FY2022, #65 in FY2023 and #38 in FY2024; down 7 since FY2024.
46 $170,087
Rank history: #24 in FY2021, #16 in FY2022, #14 in FY2023 and #18 in FY2024; down 28 since FY2024.
47 $164,149
Rank history: not on the FY2021–FY2024 lists; new.
48 $157,527
Rank history: #35 in FY2021, #22 in FY2022, #24 in FY2023 and #45 in FY2024; down 3 since FY2024.
49 $154,960
Rank history: #68 in FY2021, #53 in FY2022, #72 in FY2023 and #31 in FY2024; down 18 since FY2024.
50 $146,860
Rank history: not on the FY2021 list, #31 in FY2022, #31 in FY2023 and #22 in FY2024; down 28 since FY2024.
51 $145,144
Rank history: #62 in FY2021, #46 in FY2022, #55 in FY2023 and #53 in FY2024; up 2 since FY2024.
52 $120,507
Rank history: not on the FY2021 list, #70 in FY2022, #96 in FY2023 and #83 in FY2024; up 31 since FY2024.
53 $120,400
Rank history: not on the FY2021–FY2024 lists; new.
54 $116,925
Rank history: #50 in FY2021, #67 in FY2022, #53 in FY2023 and #50 in FY2024; down 4 since FY2024.
55 $114,184
Rank history: not on the FY2021–FY2024 lists; up 107 since FY2024.
56 $113,400
Rank history: not on the FY2021 list, #51 in FY2022, #74 in FY2023 and not on the FY2024 list; returned.
57 $103,683
Rank history: not on the FY2021–FY2024 lists; new.
58 $94,348
Rank history: not on the FY2021–FY2022 lists, #57 in FY2023 and #80 in FY2024; up 22 since FY2024.
59
Research and Diagnostic Systems Inc
$89,583
Rank history: not on the FY2021–FY2023 lists and #87 in FY2024; up 28 since FY2024.
60 $77,074
Rank history: not on the FY2021–FY2024 lists; new.
61
DNA Twopointo Inc.
$75,000
Rank history: not on the FY2021–FY2022 lists, #75 in FY2023 and #74 in FY2024; up 13 since FY2024.
62 $68,000
Rank history: not on the FY2021–FY2022 lists, #54 in FY2023 and not on the FY2024 list; returned.
63
Gemini Bioproducts LLC
$63,466
Rank history: not on the FY2021–FY2023 lists and #56 in FY2024; down 7 since FY2024.
64
Litron Laboratories Ltd
$53,654
Rank history: not on the FY2021–FY2024 lists; new.
65
Laboratory Corporation of America Holdings Through Laboratory Corp of America
$50,000
Rank history: not on the FY2021–FY2024 lists; new.
66 $49,336
Rank history: not on the FY2021–FY2024 lists; new.
67 $48,250
Rank history: not on the FY2021–FY2024 lists; new.
68 $47,387
Rank history: not on the FY2021–FY2024 lists; new.
69 $46,830
Rank history: not on the FY2021–FY2024 lists; up 46 since FY2024.
70
Seqwell Inc
$46,476
Rank history: not on the FY2021–FY2024 lists; up 31 since FY2024.
71 $40,078
Rank history: #16 in FY2021, #12 in FY2022, #46 in FY2023 and #36 in FY2024; down 35 since FY2024.
72 $40,000
Rank history: not on the FY2021–FY2024 lists; new.
73
Cerilliant Corporation 2 awardees, including Sigma-Aldrich, Inc. and EMD Millipore Corp
$39,949
Rank history: not on the FY2021–FY2023 lists and #29 in FY2024; down 44 since FY2024.
74 $39,704
Rank history: not on the FY2021 list, #81 in FY2022 and not on the FY2023–FY2024 lists; up 33 since FY2024.
75 $35,600
Rank history: not on the FY2021–FY2024 lists; new.
76
Charles River Laboratories International Inc. Through Charles River Laboratories, Inc.
$34,975
Rank history: not on the FY2021–FY2024 lists; new.
77 $34,630
Rank history: not on the FY2021–FY2023 lists and #98 in FY2024; up 21 since FY2024.
78 $33,631
Rank history: not on the FY2021–FY2024 lists; new.
79 $29,866
Rank history: not on the FY2021–FY2024 lists; new.
80 $28,936
Rank history: not on the FY2021–FY2024 lists; up 77 since FY2024.
81 $28,757
Rank history: not on the FY2021–FY2023 lists and #91 in FY2024; up 10 since FY2024.
82
Cambridge Isotope Laboratories Inc.
$27,885
Rank history: not on the FY2021–FY2023 lists and #88 in FY2024; up 6 since FY2024.
83 $26,217
Rank history: not on the FY2021–FY2024 lists; new.
84 $26,000
Rank history: not on the FY2021–FY2024 lists; new.
85
Stemcell Technologies Inc
$25,450
Rank history: #78 in FY2021, #45 in FY2022 and not on the FY2023–FY2024 lists; up 28 since FY2024.
86 $24,829
Rank history: not on the FY2021–FY2024 lists; new.
87 $24,092
Rank history: not on the FY2021–FY2024 lists; new.
88
Takara BIO USA Inc.
$23,687
Rank history: not on the FY2021–FY2023 lists and #76 in FY2024; down 12 since FY2024.
89 $23,149
Rank history: not on the FY2021–FY2024 lists; new.
90 $22,891
Rank history: not on the FY2021–FY2024 lists; new.
91 $22,555
Rank history: not on the FY2021–FY2024 lists; new.
92 $20,931
Rank history: not on the FY2021–FY2024 lists; new.
93 $19,800
Rank history: not on the FY2021 list, #89 in FY2022, #95 in FY2023 and not on the FY2024 list; up 33 since FY2024.
94
Danaher Corporation Through Beckman Coulter, Inc.
$18,116
Rank history: #72 in FY2021, #15 in FY2022, #37 in FY2023 and #51 in FY2024; down 43 since FY2024.
95 $16,900
Rank history: not on the FY2021–FY2024 lists; new.
96 $16,250
Rank history: not on the FY2021–FY2024 lists; up 39 since FY2024.
97 $16,110
Rank history: not on the FY2021–FY2023 lists and #69 in FY2024; down 28 since FY2024.
98
Cosmo BIO USA Inc
$14,682
Rank history: not on the FY2021–FY2024 lists; new.
99 $12,962
Rank history: not on the FY2021–FY2024 lists; up 50 since FY2024.
100 $12,720
Rank history: not on the FY2021–FY2024 lists; new.
Show 75 more

100 of 112 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $199 million obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. An awardee whose own actions mostly name no parent, and that no other company's actions name as their parent, rolls up its SAM.gov registration's chain of parent companies: it counts under the first company there that other companies' actions name as their parent, or under the parent most of a company's own actions name, whichever comes first; with neither, under the highest company in the chain with federal contracts of its own. Joint ventures stay companies of their own. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2025 ran Oct 1, 2024 – Sep 30, 2025. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2024. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2024 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 325414 contractors in FY2025?

1. Emergent Biosolutions Inc. ($55.7M), 2. Sanofi Pasteur Inc. ($42M), 3. Glaxosmithkline, LLC ($19.5M), 4. Artemis Technologies Inc. ($8.05M), 5. Seqirus Inc. ($7.64M), 6. Boehringer Ingelheim Animal Health USA Inc ($7.6M), 7. The American National Red Cross ($6.4M), 8. Octapharma USA Inc. ($5.5M), 9. Boehringer Ingelheim Animal Health France ($5.48M), 10. Seqirus USA Inc. ($4.46M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work